TRACER Trademark

Trademark Overview

On Monday, August 9, 2021, a trademark application was filed for TRACER with the United States Patent and Trademark Office. The USPTO has given the TRACER trademark a serial number of 90873284. The federal status of this trademark filing is REGISTERED as of Tuesday, December 5, 2023. This trademark is owned by Voyager Therapeutics, Inc.. The TRACER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development regarding the use of RNA-based functional screening platforms to discover, research and develop novel capsids for genetic delivery of therapies and pharmaceuticals
tracer

General Information

Serial Number90873284
Word MarkTRACER
Filing DateMonday, August 9, 2021
Status700 - REGISTERED
Status DateTuesday, December 5, 2023
Registration Number7237143
Registration DateTuesday, December 5, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Goods and ServicesBiotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development regarding the use of RNA-based functional screening platforms to discover, research and develop novel capsids for genetic delivery of therapies and pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 1, 2021
Primary Code042
First Use Anywhere DateFriday, December 31, 2021
First Use In Commerce DateFriday, December 31, 2021

Trademark Owner History

Party NameVoyager Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameVoyager Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameVoyager Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, December 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 5, 2023REGISTERED-PRINCIPAL REGISTER
Friday, November 3, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 2, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 13, 2023NON-FINAL ACTION E-MAILED
Sunday, August 13, 2023SU - NON-FINAL ACTION - WRITTEN
Tuesday, July 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 22, 2023USE AMENDMENT FILED
Tuesday, July 18, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 22, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2022NON-FINAL ACTION WRITTEN
Saturday, May 7, 2022ASSIGNED TO EXAMINER
Friday, October 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 12, 2021NEW APPLICATION ENTERED

Related Keywords

tracer research delivery therapies genetic pharmaceuticals development discover platforms develop novel